Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Efficacy of Nipocalimab, a Novel Neonatal Fragment Crystallizable Receptor Blocker, as Measured Using Quantitative Myasthenia Gravis Assessment: Findings from the Phase 3 Placebo-controlled Vivacity-MG3 Study

              Author:Ramchandren, Sindhu   Ait-Tihyaty, Maria   Turkoz, Ibrahim   Gandhi, Kavita   Nowak, Richard   

              Session Name:S34: Updates on Myasthenia Gravis  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:S34.001  

              Author Institution:Janssen Research & Development, LLC, Titusville, NJ, USA, Titusville, NJ  Department of Neurology, Yale University School of Medicine, New Haven, CT, USA, New Haven, CT  

              Molecular and Functional Characterization of Self-Reactive IgA Autoantibodies in Patients with Muscle-specific Tyrosine Kinase Myasthenia Gravis

              Author:Masi, Gianvito   Chen, Kangzhi   Pham, Minh   Wallace, Annabel   Nowak, Richard   O'Connor, Kevin   

              Session Name:S34: Updates on Myasthenia Gravis  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:S34.007  

              Author Institution:Yale University , New Haven, CT  

              Phase 3 Myasthenia Gravis Inebilizumab Trial (MINT): Efficacy and Safety Results in Patients with Generalized MG

              Author:Nowak, Richard   Utsugisawa, Kimiaki   Benatar, Michael   Ciafaloni, Emma   Leite, M. Isabel   Vissing, John   Tang, Fengming   Wu, Yanping   Rojavin, Mikhail   Rampal, Nishi   Cheng, Sue   Howard Jr., James F.   

              Session Name:PL5: Clinical Trials Plenary Session  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:PL5.005  

              Author Institution:

              Identifying Risk Factors for Exacerbation and Symptom Worsening—A Retrospective Cohort Study of Patients with Myasthenia Gravis in the United States

              Author:Choudhry, Zia   Park, Minjee   Narayanaswami, Pushpa   Souayah, Nizar   Govindarajan, Raghav   Kutch, Michael   Zurinaga Gutierrez, Amaia   Chekroun Martinot, Aurélie   Campbell, Nolan   Nowak, Richard   

              Session Name:P1: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 1  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:P1.010  

              Author Institution:Janssen Scientific Affairs, LLC, a Johnson & Johnson Company, Titusville, PA  Beth Israel Deaconess Medical Center, Boston, MA  NJMS, Westfield, NJ  HSHS St. Elizabeth Medical Group, O'Fallon, IL  Yale University School of Medicine, New Haven, CT  

              Serostatus Testing Patterns Among Individuals with Myasthenia Gravis: Implications for Patient Care

              Author:Liberman, Joshua N.   Pesa, Jacqueline   Darer, Jonathan D.   Yang, Xiaoyun   Jackson, Louis   Sergeyenko, Artem   Campbell, Nolan   Nowak, Richard   

              Session Name:P6: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 2  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:P6.030  

              Author Institution:Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Superior, CO  Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Philadelphia, PA  Yale University School of Medicine, New Haven, CT